C-Flow | Tissue Viability Assessment Technology

C-Flow redefines clinical decision-making in surgical procedures, post-operative
monitoring, and chronic conditions such as diabetic foot treatment. We provide
physicians with accessible, real-time tissue viability assessment and actionable data
across diverse clinical settings.

Need Led Innovation

Tissue Health Assessment

Accurate and accessible assessment of tissue health is crucial for achieving successful surgical outcomes, personalized treatment plans, and effective management of chronic conditions.

Perfusion Imaging Limitations

Existing perfusion imaging solutions fall short, lacking the accessibility to deliver comprehensive, real-time insights at the point of care. They often complicate data visibility, posing challenges for quick and accurate interpretation. These limitations significantly impede their widespread adoption across healthcare settings.

Reducing Complications

By addressing this accessibility gap in diagnostic capabilities, physicians can significantly reduce the risk of life-threatening complications like necrosis and infection, thereby decreasing the need for costly costly reoperations and revisions.

Our Solution

With a deep understanding of the challenges faced by physicians and a passion for advancing patient care, we developed the first-in-class cross-modality technology that provides accessible, real-time tissue viability assessment and actionable data.

This innovative cross-modality technology optimizes physicians’ decision-making and enables early, personalized treatment selection and better patient care.

Market Growth Through Accessibility

C-Flow’s pioneering solution enhances market growth through accessibility by making perfusion assessment available at any point of care. With simplified data outputs, C-Flow enables physicians to make:

Quicker

Safer

More cost-effective decisions at any point of care, significantly enhancing clinical outcomes.

This unprecedented accessibility expands the reach of perfusion assessment, setting a new standard in healthcare delivery.

It ensures patients receive timely, precise care, leading to improved outcomes and accelerated market growth.

Bringing advanced diagnostics to the point of care empowers healthcare providers to make faster, more informed decisions, ultimately enhancing patient safety and treatment efficacy.

Expert Team

At C-Flow, we take immense pride in our team of highly skilled and dedicated professionals who are at the forefront of revolutionizing the blood perfusion assessment market.

C-Flow was founded by a highly experienced and diverse team with extensive multi-domain knowledge. Our team includes researchers and clinicians from the Weizmann Institute of Science and Sheba Medical Center. C-Flow’s proprietary cutting-edge technology stems from years of research and practical experience.